Xencor, Inc.

XNCRNASDAQ • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
11.77 USD
↘ 0.24 (2.00%)AT CLOSE (11:59 AM EDT)
11.50
↘ 0.27 (2.29%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
11.50
↘ 0.27 (2.29%)
🔴Market: CLOSED
Open?$12.08
High?$12.08
Low?$11.55
Prev. Close?$12.01
Volume?862.6K
Avg. Volume?763.2K
VWAP?$11.80
Rel. Volume?1.13x
Bid / Ask
Bid?$11.63 × 600
Ask?$11.66 × 200
Spread?$0.03
Midpoint?$11.65
Valuation & Ratios
Market Cap?872.6M
Shares Out?74.1M
Float?74.1M
Float %?100.0%
P/E Ratio?N/A
P/B Ratio?1.69
EPS?-$2.33
Dividend?0.00%
Ex-Dividend?N/A

Shares of Xencor, Inc. (XNCR) are trading at $11.77. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place XNCR at a fair price relative to peers.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Immunology & Autoimmune
Employees
260
Market Cap
872.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.xencor.com
Listed
2013-12-03
Address
465 N. HALSTEAD ST.
PASADENA, CA 91107
Phone: 626-305-5900
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
5
Momentum?
65
Short Sent.?
28
Piotroski F-Score?2/9Weak
Altman Z-Score?0.46Distress
Confidence?59%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?14.45%High
Short Interest?10.7M
Days to Cover?12.9
Free Float74.1M
Avg Daily Volume831.3K
Settlement Date2026-05-15
Financial Health
Current Ratio?6.57Strong
Quick Ratio?6.57Strong
Cash Ratio?0.19Low
Debt/Equity?0.21Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
83
1.69CHEAP▾
P/S?
Peers
100
S&P
10
8.96HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.8CHEAP▾
EV/Sales?
Peers
100
S&P
11
9.93HIGH▾
Returns & Efficiency
ROE?
S&P
5
-33.4%WEAK▾
ROA?
S&P
3
-23.4%WEAK▾
Cash Flow & Enterprise
FCF?$-188841000
Enterprise Value?$967.0M
Fundamentals ratios updated end of day
MarketsMoversWatchlist